Ligand interaction, binding site and G protein activation of the mu opioid receptor

European Journal of Pharmacology

Volumn 702, Issue 1-3, 2013, Pages 309-315

  Cui, Xu ^a,b   Yeliseev, Alexei ^c   Liu, Renyu ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Binding site; Docking; Function; G protein activation; Mu opioid receptor; Structure

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; PARTIAL AGONIST;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ANALGESICS, OPIOID; BINDING SITES; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU;

EID: 84874936352     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.060     Document Type: Article

References (36)

1. K.P. Adinarayana, and R.K. Devi Protein-ligand interaction studies on 2, 4, 6- trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock Bioinformation 6 2011 74 77
2. Z. Bikadi, and E. Hazai Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock J. Cheminform. 1 2009 15
3. Cox, B.M. Recent developments in the study of opioid receptors. Mol Pharmacol. 10.1124/mol.112.083279, in press
4. S. Devi USA hones in on prescription drug abuse Lancet 378 2011 473 474
5. M.F. Divin, F.A. Bradbury, F.I. Carroll, and J.R. Traynor Neutral antagonist activity of naltrexone and 6beta-naltrexol in naive and opioid-dependent C6 cells expressing a mu-opioid receptor Br. J. Pharmacol. 156 2009 1044 1053
6. S. Granier, A. Manglik, A.C. Kruse, T.S. Kobilka, F.S. Thian, W.I. Weis, and B.K. Kobilka Structure of the delta-opioid receptor bound to naltrindole Nature 485 2012 400 404
7. W.W. Harding, K. Tidgewell, N. Byrd, H. Cobb, C.M. Dersch, E.R. Butelman, R.B. Rothman, and T.E. Prisinzano Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands J. Med. Chem. 48 2005 4765 4771
8. K.A. Jacobson, and S. Costanzi New insights for drug design from the X-ray crystallographic structures of g-protein-coupled receptors Mol. Pharmacol. 82 2012 361 371
9. B.M. Kuehn Opioid prescriptions soar: increase in legitimate use as well as abuse JAMA 297 2007 249 251
10. B.M. Kuehn Scientists probe ways to curb opioid abuse without hindering pain treatment JAMA 297 2007 1965 1967
11. B.M. Kuehn Efforts aim to curb opioid deaths, injuries JAMA 301 2009 1213 1215
12. J.G. Li, C. Chen, J. Yin, K. Rice, Y. Zhang, D. Matecka, J.K. de Riel, R.L. DesJarlais, and L.Y. Liu-Chen ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone Life Sci. 65 1999 175 185
13. J. Liang, H. Edelsbrunner, and C. Woodward Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design Protein Sci. 7 1998 1884 1897
14. R. Liu, J.M. Perez-Aguilar, D. Liang, and J.G. Saven Binding site and affinity prediction of general anesthetics to protein targets using docking Anesth. Analg. 114 2012 947 955
15. L. Manchikanti Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the subcommittee on criminal justice, drug policy and human resources Pain Physician 9 2006 287 321
16. L. Manchikanti, and A. Singh Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids Pain Physician 11 2008 S63 S88
17. A. Manglik, A.C. Kruse, T.S. Kobilka, F.S. Thian, J.M. Mathiesen, R.K. Sunahara, L. Pardo, W.I. Weis, B.K. Kobilka, and S. Granier Crystal structure of the mu-opioid receptor bound to a morphinan antagonist Nature 485 2012 321 326
18. G.M. Morris, D.S. Goodsell, R. Huey, and A.J. Olson Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4 J. Comput. Aided Mol. Des. 10 1996 293 304
19. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility J. Comput. Chem. 30 2009 2785 2791
20. S.M. Mumby, and M.E. Linder Myristoylation of G-protein alpha subunits Methods Enzymol. 237 1994 254 268
21. M. Nayal, and B. Honig On the nature of cavities on protein surfaces: application to the identification of drug-binding sites Proteins 63 2006 892 906
22. L.J. Paulozzi, M.F. Ballesteros, and J.A. Stevens Recent trends in mortality from unintentional injury in the United States J. Safety Res. 37 2006 277 283
23. L.J. Paulozzi, D.S. Budnitz, and Y. Xi Increasing deaths from opioid analgesics in the United States Pharmacoepidemiol Drug Saf. 15 2006 618 627
24. S. Perot, O. Sperandio, M.A. Miteva, A.C. Camproux, and B.O. Villoutreix Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery Drug Discovery Today 15 2010 656 667
25. B.L. Roth, M.B. Laskowski, and C.J. Coscia Evidence for distinct subcellular sites of opiate receptors. Demonstration of opiate receptors in smooth microsomal fractions isolated from rat brain J. Biol. Chem. 256 1981 10017 10023
26. F.J. Solis, and R.J.B. Wets Minimization by random search techniques Math. Oper. Res. 6 1981 19 30
27. J.J. Stewart MOPAC: a semiempirical molecular orbital program J. Comput. Aided Mol. Des. 4 1990 1 105
28. Y. Tang, K.X. Chen, H.L. Jiang, Z.X. Wang, R.Y. Ji, and Z.Q. Chi Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl Zhongguo Yao Li Xue Bao 17 1996 156 160
29. A.A. Thompson, W. Liu, E. Chun, V. Katritch, H. Wu, E. Vardy, X.P. Huang, C. Trapella, R. Guerrini, G. Calo, B.L. Roth, V. Cherezov, and R.C. Stevens Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic Nature 485 2012 395 399
30. D.A. Volpe, G.A. McMahon Tobin, R.D. Mellon, A.G. Katki, R.J. Parker, T. Colatsky, T.J. Kropp, and S.L. Verbois Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs Regul. Toxicol. Pharmacol. 59 2011 385 390
31. D. Wang, K.M. Raehal, E.J. Bilsky, and W. Sadee Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence J. Neurochem. 77 2001 1590 1600
32. A.G. White, H.G. Birnbaum, M.N. Mareva, M. Daher, S. Vallow, J. Schein, and N. Katz Direct costs of opioid abuse in an insured population in the United States J. Manag. Care Pharm. 11 2005 469 479
33. D.E. Wildman, H. Tamir, E. Leberer, J.K. Northup, and M. Dennis Prenyl modification of guanine nucleotide regulatory protein gamma 2 subunits is not required for interaction with the transducin alpha subunit or rhodopsin Proc. Nat. Acad. Sci. USA 90 1993 794 798
34. H. Wu, D. Wacker, M. Mileni, V. Katritch, G.W. Han, E. Vardy, W. Liu, A.A. Thompson, X.P. Huang, F.I. Carroll, S.W. Mascarella, R.B. Westkaemper, P.D. Mosier, B.L. Roth, V. Cherezov, and R.C. Stevens Structure of the human kappa-opioid receptor in complex with JDTic Nature 485 2012 327 332
35. H. Xu, Y.F. Lu, J.S. Partilla, Q.X. Zheng, J.B. Wang, G.A. Brine, F.I. Carroll, K.C. Rice, K.X. Chen, Z.Q. Chi, and R.B. Rothman Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands Synapse 32 1999 23 28
36. H. Xu, J.S. Partilla, X. Wang, J.M. Rutherford, K. Tidgewell, T.E. Prisinzano, L.M. Bohn, and R.B. Rothman A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence Synapse 61 2007 166 175